High Dose Convalescent Plasma in COVID-19: Results from the Randomized Trial CAPSID
Sixten Körper, Manfred Weiss, Daniel Zickler, Thomas Wiesmann, Kai Zacharowski, View ORCID ProfileVictor M.Corman, Beate Grüner, Lucas Ernst, Peter Spieth, Philipp M. Lepper, Martin Bentz, Sebastian Zinn, Gregor Paul, Johannes Kalbhenn, Matthias Dollinger, Peter Rosenberger, Thomas Kirschning, Thomas Thiele, Thomas Appl, Benjamin Mayer, Michael Schmidt, Christian Drosten, Hinnerk Wulf, Jan Matthias Kruse, Bettina Jungwirth, Erhard Seifried, Hubert Schrezenmeier, for the CAPSID Clinical Trial Group
doi: https://doi.org/10.1101/2021.05.10.21256192
Sixten Körper
1Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm and Institute of Transfusion Medicine, University of Ulm
Manfred Weiss
2Department of Anaesthesiology and Intensive Care Medicine, University Hospital Ulm, Ulm University, Ulm, Germany
Daniel Zickler
3Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, corporate member of Free University Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
Thomas Wiesmann
4Department of Anaesthesiology and Intensive Care Medicine, Phillips-University Marburg, Marburg, Germany
Kai Zacharowski
5Clinic of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt, Germany
Victor M.Corman
6Institute of Virology, Charité- University Medicine Berlin, corporate member of Free University Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health and German Centre for Infection Research, Berlin, Germany
Beate Grüner
7Division of Infectious Diseases, University Hospital and Medical Center Ulm, Ulm, Germany
Lucas Ernst
3Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, corporate member of Free University Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
Peter Spieth
8Department of Anesthesiology and Critical Care Medicine, Carl Gustav Carus University Hospital, Technische Universität Dresden, Dresden, Germany
Philipp M. Lepper
9Department of Internal Medicine V – Pneumology, Allergology, Intensive Care Medicine, Saarland University Hospital, Homburg, Germany
Martin Bentz
10Department of Internal Medicine III, Hospital of Karlsruhe, Karlsruhe, Germany
Sebastian Zinn
5Clinic of Anaesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Frankfurt, Germany
Gregor Paul
11Department of Gastroenterology, Hepatology, Pneumology and Infectious Diseases, Klinikum Stuttgart, Stuttgart, Germany
Johannes Kalbhenn
12Clinic of Anesthesiology and Intensive Care Medicine University Medical Center of Freiburg, Germany
Matthias Dollinger
13Medical Clinic I, Klinikum Landshut, Landshut, Germany
Peter Rosenberger
14Department of Anesthesiology and Intensive Care Medicine, University Hospital Tübingen, Tübingen, Germany
Thomas Kirschning
15Clinic for Anesthesiology and Surgical Intensive Care Medicine, University of Mannheim, Mannheim, Germany
Thomas Thiele
16Institute of Immunology and Transfusion Medicine, University Hospital Greifswald, Greifswald, Germany
Thomas Appl
1Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm and Institute of Transfusion Medicine, University of Ulm
Benjamin Mayer
17Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany
Michael Schmidt
18Institute of Transfusion Medicine and Immunohematology, German Red Cross Blood Transfusion Service Baden-Württemberg – Hessen, Frankfurt, Germany
Christian Drosten
6Institute of Virology, Charité- University Medicine Berlin, corporate member of Free University Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health and German Centre for Infection Research, Berlin, Germany
Hinnerk Wulf
4Department of Anaesthesiology and Intensive Care Medicine, Phillips-University Marburg, Marburg, Germany
Jan Matthias Kruse
3Department of Nephrology and Medical Intensive Care, Charité - Universitätsmedizin Berlin, corporate member of Free University Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany
Bettina Jungwirth
2Department of Anaesthesiology and Intensive Care Medicine, University Hospital Ulm, Ulm University, Ulm, Germany
Erhard Seifried
18Institute of Transfusion Medicine and Immunohematology, German Red Cross Blood Transfusion Service Baden-Württemberg – Hessen, Frankfurt, Germany
Hubert Schrezenmeier
1Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm and Institute of Transfusion Medicine, University of Ulm
- Online Supplement[supplements/256192_file07.pdf]
- Clinical Trial Group[supplements/256192_file08.pdf]
Posted May 10, 2021.
High Dose Convalescent Plasma in COVID-19: Results from the Randomized Trial CAPSID
Sixten Körper, Manfred Weiss, Daniel Zickler, Thomas Wiesmann, Kai Zacharowski, Victor M.Corman, Beate Grüner, Lucas Ernst, Peter Spieth, Philipp M. Lepper, Martin Bentz, Sebastian Zinn, Gregor Paul, Johannes Kalbhenn, Matthias Dollinger, Peter Rosenberger, Thomas Kirschning, Thomas Thiele, Thomas Appl, Benjamin Mayer, Michael Schmidt, Christian Drosten, Hinnerk Wulf, Jan Matthias Kruse, Bettina Jungwirth, Erhard Seifried, Hubert Schrezenmeier, for the CAPSID Clinical Trial Group
medRxiv 2021.05.10.21256192; doi: https://doi.org/10.1101/2021.05.10.21256192
High Dose Convalescent Plasma in COVID-19: Results from the Randomized Trial CAPSID
Sixten Körper, Manfred Weiss, Daniel Zickler, Thomas Wiesmann, Kai Zacharowski, Victor M.Corman, Beate Grüner, Lucas Ernst, Peter Spieth, Philipp M. Lepper, Martin Bentz, Sebastian Zinn, Gregor Paul, Johannes Kalbhenn, Matthias Dollinger, Peter Rosenberger, Thomas Kirschning, Thomas Thiele, Thomas Appl, Benjamin Mayer, Michael Schmidt, Christian Drosten, Hinnerk Wulf, Jan Matthias Kruse, Bettina Jungwirth, Erhard Seifried, Hubert Schrezenmeier, for the CAPSID Clinical Trial Group
medRxiv 2021.05.10.21256192; doi: https://doi.org/10.1101/2021.05.10.21256192
Subject Area
Subject Areas
- Addiction Medicine (157)
- Allergy and Immunology (412)
- Anesthesia (90)
- Cardiovascular Medicine (852)
- Dermatology (97)
- Emergency Medicine (247)
- Epidemiology (8527)
- Gastroenterology (381)
- Genetic and Genomic Medicine (1731)
- Geriatric Medicine (166)
- Health Economics (370)
- Health Informatics (1232)
- Health Policy (615)
- Hematology (196)
- HIV/AIDS (367)
- Medical Education (192)
- Medical Ethics (51)
- Nephrology (209)
- Neurology (1662)
- Nursing (97)
- Nutrition (247)
- Oncology (918)
- Ophthalmology (261)
- Orthopedics (99)
- Otolaryngology (172)
- Pain Medicine (110)
- Palliative Medicine (40)
- Pathology (249)
- Pediatrics (532)
- Primary Care Research (205)
- Public and Global Health (3814)
- Radiology and Imaging (620)
- Respiratory Medicine (518)
- Rheumatology (204)
- Sports Medicine (156)
- Surgery (188)
- Toxicology (36)
- Transplantation (99)
- Urology (74)